Wanted categories

From Wicri Health

Showing below up to 311 results in range #1 to #311.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Humans (MeSH)‏‎ (23 members)
  2. Middle Aged (MeSH)‏‎ (15 members)
  3. Male (MeSH)‏‎ (14 members)
  4. Female (MeSH)‏‎ (13 members)
  5. Aged (MeSH)‏‎ (11 members)
  6. Influenza, Human (epidemiology)‏‎ (9 members)
  7. Adolescent (MeSH)‏‎ (8 members)
  8. Imported vocabulary‏‎ (7 members)
  9. Young Adult (MeSH)‏‎ (7 members)
  10. Animals (MeSH)‏‎ (6 members)
  11. Child (MeSH)‏‎ (6 members)
  12. Pandemics (MeSH)‏‎ (6 members)
  13. Risk Factors (MeSH)‏‎ (6 members)
  14. Aged, 80 and over (MeSH)‏‎ (5 members)
  15. Child, Preschool (MeSH)‏‎ (5 members)
  16. Disease Outbreaks (MeSH)‏‎ (5 members)
  17. Germany (epidemiology)‏‎ (5 members)
  18. Infant (MeSH)‏‎ (5 members)
  19. Influenza, Human (virology)‏‎ (5 members)
  20. France (epidemiology)‏‎ (4 members)
  21. Influenza in Birds (virology)‏‎ (4 members)
  22. Pages with ignored display titles‏‎ (4 members)
  23. Prospective Studies (MeSH)‏‎ (4 members)
  24. Respiratory Tract Infections (epidemiology)‏‎ (4 members)
  25. Coronavirus Infections (epidemiology)‏‎ (3 members)
  26. Influenza A Virus, H1N1 Subtype (isolation & purification)‏‎ (3 members)
  27. Pneumonia, Viral (epidemiology)‏‎ (3 members)
  28. Respiratory Tract Infections (virology)‏‎ (3 members)
  29. Retrospective Studies (MeSH)‏‎ (3 members)
  30. Seasons (MeSH)‏‎ (3 members)
  31. Surveys and Questionnaires (MeSH)‏‎ (3 members)
  32. Travel (MeSH)‏‎ (3 members)
  33. Animals, Wild (MeSH)‏‎ (2 members)
  34. Betacoronavirus (MeSH)‏‎ (2 members)
  35. Canada (epidemiology)‏‎ (2 members)
  36. City‏‎ (2 members)
  37. Comorbidity (MeSH)‏‎ (2 members)
  38. Coronavirus Infections (complications)‏‎ (2 members)
  39. Diagnosis, Differential (MeSH)‏‎ (2 members)
  40. Disease Outbreaks (prevention & control)‏‎ (2 members)
  41. Disease Outbreaks (statistics & numerical data)‏‎ (2 members)
  42. Disease Outbreaks (veterinary)‏‎ (2 members)
  43. Incidence (MeSH)‏‎ (2 members)
  44. Infant, Newborn (MeSH)‏‎ (2 members)
  45. Influenza, Human (diagnosis)‏‎ (2 members)
  46. Influenza, Human (prevention & control)‏‎ (2 members)
  47. Influenza A Virus, H1N1 Subtype (immunology)‏‎ (2 members)
  48. Influenza A virus (isolation & purification)‏‎ (2 members)
  49. Influenza in Birds (transmission)‏‎ (2 members)
  50. Netherlands (epidemiology)‏‎ (2 members)
  51. Nystagmus, Pathologic (diagnosis)‏‎ (2 members)
  52. Pandemics (prevention & control)‏‎ (2 members)
  53. Person‏‎ (2 members)
  54. Pneumonia, Viral (complications)‏‎ (2 members)
  55. Population Surveillance (MeSH)‏‎ (2 members)
  56. Severity of Illness Index (MeSH)‏‎ (2 members)
  57. Time Factors (MeSH)‏‎ (2 members)
  58. Vertigo (diagnosis)‏‎ (2 members)
  59. Academic establishment‏‎ (1 member)
  60. Activities of Daily Living (psychology)‏‎ (1 member)
  61. Adaptation, Psychological (MeSH)‏‎ (1 member)
  62. Adolescent Behavior (ethnology)‏‎ (1 member)
  63. Adolescent Behavior (physiology)‏‎ (1 member)
  64. Adolescent Behavior (psychology)‏‎ (1 member)
  65. Age Factors (MeSH)‏‎ (1 member)
  66. Agricultural Workers' Diseases (epidemiology)‏‎ (1 member)
  67. Agricultural Workers' Diseases (virology)‏‎ (1 member)
  68. Alaska (epidemiology)‏‎ (1 member)
  69. Alberta (epidemiology)‏‎ (1 member)
  70. Animal Husbandry (standards)‏‎ (1 member)
  71. Animal Migration (MeSH)‏‎ (1 member)
  72. Animals, Domestic (MeSH)‏‎ (1 member)
  73. Anniversaries and Special Events (MeSH)‏‎ (1 member)
  74. Antibiotic Prophylaxis (MeSH)‏‎ (1 member)
  75. Antibodies, Viral (blood)‏‎ (1 member)
  76. Anticholesteremic Agents (therapeutic use)‏‎ (1 member)
  77. Antiviral Agents (therapeutic use)‏‎ (1 member)
  78. Anxiety (etiology)‏‎ (1 member)
  79. Anxiety (psychology)‏‎ (1 member)
  80. Aphthovirus (genetics)‏‎ (1 member)
  81. Attitude of Health Personnel (MeSH)‏‎ (1 member)
  82. Behavior, Addictive (etiology)‏‎ (1 member)
  83. Betacoronavirus (isolation & purification)‏‎ (1 member)
  84. Betacoronavirus (pathogenicity)‏‎ (1 member)
  85. Birds (MeSH)‏‎ (1 member)
  86. Boredom (MeSH)‏‎ (1 member)
  87. British Columbia (epidemiology)‏‎ (1 member)
  88. Bronchoalveolar Lavage Fluid (microbiology)‏‎ (1 member)
  89. Burnout, Professional (etiology)‏‎ (1 member)
  90. COVID-19 (MeSH)‏‎ (1 member)
  91. COVID-19 (diagnosis)‏‎ (1 member)
  92. COVID-19 Testing (methods)‏‎ (1 member)
  93. Calculi (diagnosis)‏‎ (1 member)
  94. Canada (MeSH)‏‎ (1 member)
  95. Carcinoma, Hepatocellular (epidemiology)‏‎ (1 member)
  96. Carcinoma, Hepatocellular (etiology)‏‎ (1 member)
  97. Cardiovascular Diseases (complications)‏‎ (1 member)
  98. Cattle (MeSH)‏‎ (1 member)
  99. Cattle Diseases (epidemiology)‏‎ (1 member)
  100. Cattle Diseases (virology)‏‎ (1 member)
  101. Cerebellar Diseases (diagnosis)‏‎ (1 member)
  102. Child Behavior (ethnology)‏‎ (1 member)
  103. Child Behavior (physiology)‏‎ (1 member)
  104. Child Behavior (psychology)‏‎ (1 member)
  105. Child Rearing (ethnology)‏‎ (1 member)
  106. Child Rearing (history)‏‎ (1 member)
  107. Child Rearing (psychology)‏‎ (1 member)
  108. Child Welfare (economics)‏‎ (1 member)
  109. Child Welfare (ethnology)‏‎ (1 member)
  110. Child Welfare (history)‏‎ (1 member)
  111. Child Welfare (psychology)‏‎ (1 member)
  112. China (MeSH)‏‎ (1 member)
  113. China (epidemiology)‏‎ (1 member)
  114. Clinical Laboratory Techniques (statistics & numerical data)‏‎ (1 member)
  115. Cohort Studies (MeSH)‏‎ (1 member)
  116. Communicable Diseases, Emerging (epidemiology)‏‎ (1 member)
  117. Community-Acquired Infections (epidemiology)‏‎ (1 member)
  118. Community-Acquired Infections (virology)‏‎ (1 member)
  119. Conjunctivitis, Viral (epidemiology)‏‎ (1 member)
  120. Conjunctivitis, Viral (transmission)‏‎ (1 member)
  121. Conjunctivitis, Viral (virology)‏‎ (1 member)
  122. Contact Tracing (MeSH)‏‎ (1 member)
  123. Coronavirus, Bovine (genetics)‏‎ (1 member)
  124. Coronavirus Infections (MeSH)‏‎ (1 member)
  125. Coronavirus Infections (mortality)‏‎ (1 member)
  126. Coronavirus Infections (prevention & control)‏‎ (1 member)
  127. Coronavirus Infections (therapy)‏‎ (1 member)
  128. Coronavirus Infections (transmission)‏‎ (1 member)
  129. Coronavirus Infections (virology)‏‎ (1 member)
  130. Cross-Sectional Studies (MeSH)‏‎ (1 member)
  131. Databases, Factual (MeSH)‏‎ (1 member)
  132. Delivery of Health Care (MeSH)‏‎ (1 member)
  133. Depression (etiology)‏‎ (1 member)
  134. Ducks (virology)‏‎ (1 member)
  135. Education (economics)‏‎ (1 member)
  136. Education (history)‏‎ (1 member)
  137. Emergency Service, Hospital (MeSH)‏‎ (1 member)
  138. Fear (psychology)‏‎ (1 member)
  139. Fever (epidemiology)‏‎ (1 member)
  140. Fever (virology)‏‎ (1 member)
  141. Follow-Up Studies (MeSH)‏‎ (1 member)
  142. Genetic Variation (MeSH)‏‎ (1 member)
  143. Genome, Viral (genetics)‏‎ (1 member)
  144. Geography‏‎ (1 member)
  145. Head Movements (physiology)‏‎ (1 member)
  146. Health Personnel (psychology)‏‎ (1 member)
  147. Health Services Research (MeSH)‏‎ (1 member)
  148. Health Workforce (MeSH)‏‎ (1 member)
  149. Helplessness, Learned (MeSH)‏‎ (1 member)
  150. Hemagglutination Inhibition Tests (MeSH)‏‎ (1 member)
  151. Hemagglutinin Glycoproteins, Influenza Virus (genetics)‏‎ (1 member)
  152. Hepatitis B, Chronic (complications)‏‎ (1 member)
  153. Hepatitis B, Chronic (epidemiology)‏‎ (1 member)
  154. Hepatitis B (complications)‏‎ (1 member)
  155. Hepatitis B (epidemiology)‏‎ (1 member)
  156. History, 17th Century (MeSH)‏‎ (1 member)
  157. History, 18th Century (MeSH)‏‎ (1 member)
  158. Hospitalization (MeSH)‏‎ (1 member)
  159. Hospitalization (statistics & numerical data)‏‎ (1 member)
  160. Infection Control (methods)‏‎ (1 member)
  161. Infectious Disease Transmission, Patient-to-Professional (prevention & control)‏‎ (1 member)
  162. Influenza, Human (complications)‏‎ (1 member)
  163. Influenza, Human (genetics)‏‎ (1 member)
  164. Influenza, Human (therapy)‏‎ (1 member)
  165. Influenza, Human (transmission)‏‎ (1 member)
  166. Influenza, Human (veterinary)‏‎ (1 member)
  167. Influenza A Virus, H1N1 Subtype (MeSH)‏‎ (1 member)
  168. Influenza A Virus, H5N1 Subtype (genetics)‏‎ (1 member)
  169. Influenza A Virus, H5N1 Subtype (pathogenicity)‏‎ (1 member)
  170. Influenza A Virus, H5N8 Subtype (MeSH)‏‎ (1 member)
  171. Influenza A Virus, H7N7 Subtype (MeSH)‏‎ (1 member)
  172. Influenza A Virus, H7N7 Subtype (genetics)‏‎ (1 member)
  173. Influenza A Virus, H7N7 Subtype (pathogenicity)‏‎ (1 member)
  174. Influenza A Virus, H7N9 Subtype (isolation & purification)‏‎ (1 member)
  175. Influenza A Virus, H9N2 Subtype (genetics)‏‎ (1 member)
  176. Influenza A Virus, H9N2 Subtype (pathogenicity)‏‎ (1 member)
  177. Influenza A virus (genetics)‏‎ (1 member)
  178. Influenza A virus (pathogenicity)‏‎ (1 member)
  179. Influenza Pandemic, 1918-1919 (MeSH)‏‎ (1 member)
  180. Influenza Vaccines (administration & dosage)‏‎ (1 member)
  181. Influenza Vaccines (immunology)‏‎ (1 member)
  182. Influenza in Birds (genetics)‏‎ (1 member)
  183. Intensive Care Units (MeSH)‏‎ (1 member)
  184. Labyrinth Diseases (diagnosis)‏‎ (1 member)
  185. Length of Stay (MeSH)‏‎ (1 member)
  186. Liver Failure, Acute (epidemiology)‏‎ (1 member)
  187. Liver Failure, Acute (etiology)‏‎ (1 member)
  188. Liver Neoplasms (epidemiology)‏‎ (1 member)
  189. Liver Neoplasms (etiology)‏‎ (1 member)
  190. Lung Transplantation (adverse effects)‏‎ (1 member)
  191. Measles (epidemiology)‏‎ (1 member)
  192. Medicine‏‎ (1 member)
  193. Metagenomics (MeSH)‏‎ (1 member)
  194. Molecular Epidemiology (methods)‏‎ (1 member)
  195. Myocardium (pathology)‏‎ (1 member)
  196. Neurologic Examination (MeSH)‏‎ (1 member)
  197. Nocardia (genetics)‏‎ (1 member)
  198. Nocardia (isolation & purification)‏‎ (1 member)
  199. Nocardia Infections (diagnosis)‏‎ (1 member)
  200. Nystagmus, Pathologic (etiology)‏‎ (1 member)
  201. Nystagmus, Pathologic (physiopathology)‏‎ (1 member)
  202. Nystagmus, Pathologic (therapy)‏‎ (1 member)
  203. Occupational Diseases (etiology)‏‎ (1 member)
  204. Occupational Diseases (psychology)‏‎ (1 member)
  205. Opportunistic Infections (microbiology)‏‎ (1 member)
  206. Orientation (physiology)‏‎ (1 member)
  207. Oseltamivir (therapeutic use)‏‎ (1 member)
  208. Page being created‏‎ (1 member)
  209. Pages with broken file links‏‎ (1 member)
  210. Paris (ethnology)‏‎ (1 member)
  211. Patient Care Team (organization & administration)‏‎ (1 member)
  212. Phylogeny (MeSH)‏‎ (1 member)
  213. Pilot Projects (MeSH)‏‎ (1 member)
  214. Pneumonia, Viral (MeSH)‏‎ (1 member)
  215. Pneumonia, Viral (mortality)‏‎ (1 member)
  216. Pneumonia, Viral (prevention & control)‏‎ (1 member)
  217. Pneumonia, Viral (therapy)‏‎ (1 member)
  218. Pneumonia, Viral (transmission)‏‎ (1 member)
  219. Pneumonia, Viral (virology)‏‎ (1 member)
  220. Polymerase Chain Reaction (MeSH)‏‎ (1 member)
  221. Population Control (methods)‏‎ (1 member)
  222. Postural Balance (MeSH)‏‎ (1 member)
  223. Posture (MeSH)‏‎ (1 member)
  224. Posture (physiology)‏‎ (1 member)
  225. Poultry (MeSH)‏‎ (1 member)
  226. Poultry (virology)‏‎ (1 member)
  227. Prevalence (MeSH)‏‎ (1 member)
  228. Prognosis (MeSH)‏‎ (1 member)
  229. Prone Position (MeSH)‏‎ (1 member)
  230. Protective Devices (supply & distribution)‏‎ (1 member)
  231. Punishment (history)‏‎ (1 member)
  232. Punishment (psychology)‏‎ (1 member)
  233. Quality-Adjusted Life Years (MeSH)‏‎ (1 member)
  234. Quarantine (methods)‏‎ (1 member)
  235. Quarantine (psychology)‏‎ (1 member)
  236. RNA, Ribosomal, 16S (genetics)‏‎ (1 member)
  237. RNA, Viral (genetics)‏‎ (1 member)
  238. RNA Replicase (genetics)‏‎ (1 member)
  239. RNA Virus Infections (epidemiology)‏‎ (1 member)
  240. RNA Virus Infections (veterinary)‏‎ (1 member)
  241. RNA Virus Infections (virology)‏‎ (1 member)
  242. RNA Viruses (genetics)‏‎ (1 member)
  243. Reassortant Viruses (genetics)‏‎ (1 member)
  244. Reference page for article‏‎ (1 member)
  245. Reference page for bibliographic référence‏‎ (1 member)
  246. Reflex (MeSH)‏‎ (1 member)
  247. Religion (history)‏‎ (1 member)
  248. Resilience, Psychological (MeSH)‏‎ (1 member)
  249. Respiration, Artificial (MeSH)‏‎ (1 member)
  250. Respiration, Artificial (methods)‏‎ (1 member)
  251. Respiratory Distress Syndrome, Adult (epidemiology)‏‎ (1 member)
  252. Respiratory Distress Syndrome, Adult (etiology)‏‎ (1 member)
  253. Respiratory Distress Syndrome, Adult (therapy)‏‎ (1 member)
  254. Respiratory Distress Syndrome, Adult (virology)‏‎ (1 member)
  255. Respiratory Syncytial Virus, Bovine (genetics)‏‎ (1 member)
  256. Respiratory Syncytial Virus, Human (isolation & purification)‏‎ (1 member)
  257. Respiratory Syncytial Virus Infections (diagnosis)‏‎ (1 member)
  258. Respiratory Syncytial Virus Infections (epidemiology)‏‎ (1 member)
  259. Respiratory Syncytial Virus Infections (virology)‏‎ (1 member)
  260. Respiratory Tract Infections (diagnosis)‏‎ (1 member)
  261. Respiratory Tract Infections (drug therapy)‏‎ (1 member)
  262. Respiratory Tract Infections (therapy)‏‎ (1 member)
  263. Respiratory Tract Infections (veterinary)‏‎ (1 member)
  264. SARS-CoV-2 (MeSH)‏‎ (1 member)
  265. Sadness (psychology)‏‎ (1 member)
  266. Safety (MeSH)‏‎ (1 member)
  267. Salmonella Infections (epidemiology)‏‎ (1 member)
  268. Saudi Arabia (epidemiology)‏‎ (1 member)
  269. Schizophrenic Psychology (MeSH)‏‎ (1 member)
  270. Self Medication (MeSH)‏‎ (1 member)
  271. Semicircular Canals (MeSH)‏‎ (1 member)
  272. Sensitivity and Specificity (MeSH)‏‎ (1 member)
  273. Sequence Analysis (MeSH)‏‎ (1 member)
  274. Seroepidemiologic Studies (MeSH)‏‎ (1 member)
  275. Severe Acute Respiratory Syndrome (epidemiology)‏‎ (1 member)
  276. Severe Acute Respiratory Syndrome (psychology)‏‎ (1 member)
  277. Sex Factors (MeSH)‏‎ (1 member)
  278. Singing (MeSH)‏‎ (1 member)
  279. Smoking (genetics)‏‎ (1 member)
  280. Smoking (psychology)‏‎ (1 member)
  281. Smoking Cessation (methods)‏‎ (1 member)
  282. Social Conditions (economics)‏‎ (1 member)
  283. Social Conditions (history)‏‎ (1 member)
  284. Social Support (MeSH)‏‎ (1 member)
  285. Socioeconomic Factors (MeSH)‏‎ (1 member)
  286. Sociological factors‏‎ (1 member)
  287. Stress Disorders, Post-Traumatic (MeSH)‏‎ (1 member)
  288. Students (history)‏‎ (1 member)
  289. Students (legislation & jurisprudence)‏‎ (1 member)
  290. Students (psychology)‏‎ (1 member)
  291. Suicide (psychology)‏‎ (1 member)
  292. Suicide (statistics & numerical data)‏‎ (1 member)
  293. Syndrome (MeSH)‏‎ (1 member)
  294. Thogotovirus (genetics)‏‎ (1 member)
  295. Treatment Outcome (MeSH)‏‎ (1 member)
  296. Tunisia (MeSH)‏‎ (1 member)
  297. Turkeys (virology)‏‎ (1 member)
  298. Uncertainty (MeSH)‏‎ (1 member)
  299. University‏‎ (1 member)
  300. Vaccination (MeSH)‏‎ (1 member)
  301. Vertigo (etiology)‏‎ (1 member)
  302. Vertigo (physiopathology)‏‎ (1 member)
  303. Vestibular Function Tests (MeSH)‏‎ (1 member)
  304. Viral Proteins (genetics)‏‎ (1 member)
  305. Washington (epidemiology)‏‎ (1 member)
  306. Wikipedia‏‎ (1 member)
  307. Work Schedule Tolerance (psychology)‏‎ (1 member)
  308. Workload (MeSH)‏‎ (1 member)
  309. Yukon Territory (epidemiology)‏‎ (1 member)
  310. Zoonoses (epidemiology)‏‎ (1 member)
  311. Zoonoses (transmission)‏‎ (1 member)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)